The Autoimmune CAGT playbook is here
DOWNLOAD THE INSIGHT BRIEF: Navigating Autoimmune Disease

As cell and gene therapy development continues to evolve with rapid advancement — biotech sponsors can apply the knowledge gained from oncology studies to navigate the challenges of this dynamic space.

In this new insight brief, IQVIA Biotech experts outline a strategic playbook for navigating autoimmune CAGT development. Learn how to:
  • Design patient-centric trials for chronic autoimmune conditions
  • Prepare sites and multidisciplinary teams for execution
  • Overcome regulatory and logistical complexities
  • Build early commercialization strategies to stand out in a growing field

Download to access strategic insights and expert perspectives.
Get your copy of IQVIA Biotech’s insight brief and explore the clinical, regulatory and commercial strategies that drive success in autoimmune CAGT trials.

Complete the form to download the insight brief.
By selecting this box, I consent to receive communications about IQVIA's offering by email.
Authored by our Cell and Gene Therapy experts
Erin Finot
 Vice President, Immuno-Oncology and
Cell & Gene Therapy
IQVIA Biotech
Jessica Knight-Perry, MD
Senior Director, Medical Strategy Lead,
Cell & Gene Therapy Center of Excellence
IQVIA
Emily Smith
Therapeutic Strategy Lead,
Cell & Gene Therapy Center of Excellence
IQVIA

Copyright © 2026 IQVIA Holdings Inc. and its affiliates. All rights reserved. Privacy Statement

DO NOT SELL MY PERSONAL INFORMATION